Radcliffe Capital Management, L.P. - THERAVANCE INC ownership

THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 29 filers reported holding THERAVANCE INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2022$27,654,774
+463.0%
27,688,000
+453.8%
0.88%
+641.5%
Q3 2022$4,912,000
-84.5%
5,000,000
-83.1%
0.12%
-87.2%
Q3 2021$31,694,000
+5.7%
29,500,0000.0%0.92%
-1.8%
Q2 2021$29,979,000
+360.9%
29,500,000
+353.8%
0.94%
+261.2%
Q1 2021$6,504,000
+0.6%
6,500,0000.0%0.26%
-35.8%
Q4 2020$6,465,0006,500,0000.40%
Other shareholders
THERAVANCE INC shareholders Q1 2021
NameSharesValueWeighting ↓
Wellesley Asset Management 41,771$44,921,0002.37%
LINDEN ADVISORS LP 45,495,000$48,853,0001.16%
BASSO CAPITAL MANAGEMENT, L.P. 4,759,000$5,092,0000.94%
SSI INVESTMENT MANAGEMENT LLC 6,850,000$7,332,0000.60%
TEALWOOD ASSET MANAGEMENT INC 1,390,000$1,492,0000.59%
Castle Creek Arbitrage, LLC 6,070,000$6,516,0000.48%
OAKTREE CAPITAL MANAGEMENT LP 21,717,000$23,355,0000.37%
AQR Arbitrage LLC 27,018,000$29,055,0000.34%
CSS LLC/IL 5,000,000$5,360,0000.27%
CQS Cayman LP 4,150,000$4,469,0000.21%
View complete list of THERAVANCE INC shareholders